Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Good Girl Rx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Good Girl Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 165 · Grade C

Good Girl Rx

Visit Good Girl Rx Full brief →

FDA warning letter, February 2026 — issued to Good Girl LLC dba GoodGirlRX. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 70 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Good Girl Rx a bad call — it's best for patients seeking multiple compounded glp-1 formats with pharmacy quality standards. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
77
Transparency
90
88
Access Breadth
93
97
Clinical Oversight
92
73
Track Record
88
56
CoreAge RxBrief Score 94 · 70Good Girl Rx

Price, coverage & the tracker

CoreAge RxGood Girl Rx
Brief Score94/100 (A)70/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not publishedFrom $79/mo (microdose tier, 12-month plan, compounded)
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not publishedFrom $139/mo (microdose tier, 12-month plan, compounded)
CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Good Girl Rx: New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://goodgirlrx.com/ on 2026-08-01 and this row reflects what that page says. The line we publish is From $79/mo (microdose tier, 12-month plan, compounded). There is no earlier reading of ours to compare it against yet.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.